HLA-I Associated Adaptation Dampens CD8 T-Cell Responses in HIV Ad5-Vectored Vaccine Recipients

J Infect Dis. 2019 Oct 8;220(10):1620-1628. doi: 10.1093/infdis/jiz368.

Abstract

HLA-I-associated human immunodeficiency virus (HIV) adaptation is known to negatively affect disease progression and CD8 T-cell responses. We aimed to assess how HLA-I-associated adaptation affects HIV vaccine-induced CD8 T-cell responses in 2 past vaccine efficacy trials. We found that vaccine-encoded adapted epitopes were less immunogenic than vaccine-encoded nonadapted epitopes, and adapted epitope-specific responses were less polyfunctional than nonadapted epitope-specific responses. Along those lines, vaccine recipients with higher HLA-I adaptation to the Gag vaccine insert mounted less polyfunctional CD8 T-cell responses at the protein level. Breadth of response, which correlated with viral control in recipients who became infected, is also dampened by HLA-I adaptation. These findings suggest that HLA-I-associated adaptation is an important consideration for strategies aiming to induce robust CD8 T-cell responses.

Keywords: HIV-1 vaccine; HIV-specific CD8 T cells; HLA-I; HVTN 502; HVTN 505; adapted epitopes; associated adaptation; polyfunctionality.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / immunology*
  • Adaptation, Biological*
  • Adenoviridae / genetics
  • CD8-Positive T-Lymphocytes / immunology*
  • Drug Carriers
  • Epitopes / immunology*
  • Genetic Vectors
  • HIV Infections / prevention & control*
  • Histocompatibility Antigens Class I / metabolism*
  • Humans
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / immunology
  • gag Gene Products, Human Immunodeficiency Virus / immunology*

Substances

  • AIDS Vaccines
  • Drug Carriers
  • Epitopes
  • Histocompatibility Antigens Class I
  • Vaccines, Synthetic
  • gag Gene Products, Human Immunodeficiency Virus